Skip to search formSkip to main contentSkip to account menu

adinazolam mesylate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The pharmacokinetics and pharmacodynamics of adinazolam were studied in 15 normal, healthy, non-obse volunteers. Placebo capsules… 
1994
1994
Alterations in brain norepinephrine (NE) have been implicated in depression, bipolar disorders, and schizophrenia. The locus… 
1992
1992
SummaryAdinazolam, a triazolobenzodiazepine, has been studied in the treatment of depression, panic disorder and anxiety. N… 
1991
1991
The pharmacokinetics of adinazolam and N-desmethyladinazolam (NDMAD) were studied in 14 healthy male volunteers who received 15… 
1990
1990
The tolerance, pharmacokinetics, and pharmacodynamics of adinazolam and N‐desmethyladinazolam (NDMAD) were assessed after single… 
1990
1990
Thirty outpatients between the ages of 60 and 85 with DSM-III Major Depression entered an 8 week randomized, double-blind… 
1988
1988
In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly… 
1988
1988
In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly… 
1984
1984
A procedure for the quantitative determination of adinazolam in plasma was developed. The drug, an N-demethylated metabolite, and…